Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study. [electronic resource]
Producer: 20051027Description: 6561-8 p. digitalISSN:- 0732-183X
- Age Factors
- Aged
- Aged, 80 and over
- Analysis of Variance
- Androgen Antagonists -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Dose-Response Relationship, Radiation
- Follow-Up Studies
- Humans
- Logistic Models
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Probability
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- drug therapy
- Radiotherapy Dosage
- Radiotherapy, Conformal -- methods
- Risk Assessment
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.